ExodusPoint Capital Management »

Cytokinetics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.0M 205k 29.46
2023-06-30 $6.9M 213k 32.62
2023-03-31 $9.5M 270k 35.19
2022-12-31 $7.4M 161k 45.82
2022-06-30 $3.9M 99k 39.29
2021-12-31 $1.2M 26k 45.59
2021-09-30 $2.7M 77k 35.74
2021-06-30 $624k 32k 19.80
2021-03-31 $1.2M 54k 23.26
2019-12-31 $206k 19k 10.63

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
CMS Energy Corporation (CMS)
Select Sector Spdr Tr Energy Call Option (XLE)
PPL Corporation (PPL)
Exelon Corporation (EXC)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NiSource (NI)
Vmware Cl A Com
Exxon Mobil Corporation (XOM)
Select Sector Spdr Tr Financial Put Option (XLF)
Microsoft Corporation Call Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics